 | • レポートコード：QAF27798 • 出版社/出版日：QYResearch / 2021年4月6日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のナノ医薬品市場について種類別（リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルジョン・ナノエマルジョン、ナノ懸濁液）、用途別（がん・腫瘍、自己免疫疾患、炎症、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ナノ医薬品市場の概要 ・世界の主要地域別ナノ医薬品市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のナノ医薬品市場規模2016-2021：種類別（リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルジョン・ナノエマルジョン、ナノ懸濁液） ・世界のナノ医薬品市場予測2012-2027：種類別（リポソーム、高分子ミセル、固体脂質ナノ粒子、マイクロエマルジョン・ナノエマルジョン、ナノ懸濁液） ・世界のナノ医薬品市場規模2016-2021：用途別（がん・腫瘍、自己免疫疾患、炎症、その他） ・世界のナノ医薬品市場予測2012-2027：用途別（がん・腫瘍、自己免疫疾患、炎症、その他） ・ナノ医薬品のアメリカ市場規模と予測2016-2021 ・ナノ医薬品のヨーロッパ市場規模と予測2016-2021 ・ナノ医薬品の中国市場規模と予測2016-2021 ・ナノ医薬品の日本市場規模と予測2016-2021 ・ナノ医薬品の東南アジア市場規模と予測2016-2021 ・ナノ医薬品のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Roche、Sanofi、Eli Lilly、Astrazeneca、Johnson & Johnson、Celgene、Novavax、Stryker、Gilead Sciences、OSI Pharmaceuticals、Kadmon Pharmaceuticals、Samyang Biopharm、Mitsubishi Pharma、Kaken Pharmaceutical、Selecta Biosciences、Par Pharmaceutical、Cerulean Pharma、Navidea Biopharmaceuticals、Lummy） ・ナノ医薬品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ナノ医薬品の市場動向・機会・課題 ・調査の結論 |
Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.
There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
Market Analysis and Insights: Global Nanopharmaceuticals Market
The global Nanopharmaceuticals market was valued at US$ 30960 in 2020 and will reach US$ 64460 million by the end of 2027, growing at a CAGR of 13.0% during 2022-2027.
Global Nanopharmaceuticals Scope and Market Size
The global Nanopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension
Segment by Application
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others
The Nanopharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Nanopharmaceuticals market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
1 Nanopharmaceuticals Market Overview
1.1 Nanopharmaceuticals Product Scope
1.2 Nanopharmaceuticals Segment by Type
1.2.1 Global Nanopharmaceuticals Sales by Type (2016 & 2021 & 2027)
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid Lipid Nanoparticles
1.2.5 Microemulsion and Nnanoemulsion
1.2.6 Nanosuspension
1.3 Nanopharmaceuticals Segment by Application
1.3.1 Global Nanopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Cancer and Tumor
1.3.3 Autoimmune Disorders
1.3.4 Inflammation
1.3.5 Others
1.4 Nanopharmaceuticals Market Estimates and Forecasts (2016-2027)
1.4.1 Global Nanopharmaceuticals Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Nanopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Nanopharmaceuticals Price Trends (2016-2027)
2 Nanopharmaceuticals Estimates and Forecasts by Region
2.1 Global Nanopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Nanopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Nanopharmaceuticals Sales Market Share by Region (2016-2021)
2.2.2 Global Nanopharmaceuticals Revenue Market Share by Region (2016-2021)
2.3 Global Nanopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Nanopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Nanopharmaceuticals Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Nanopharmaceuticals Estimates and Projections (2016-2027)
2.4.2 Europe Nanopharmaceuticals Estimates and Projections (2016-2027)
2.4.3 China Nanopharmaceuticals Estimates and Projections (2016-2027)
2.4.4 Japan Nanopharmaceuticals Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Nanopharmaceuticals Estimates and Projections (2016-2027)
2.4.6 India Nanopharmaceuticals Estimates and Projections (2016-2027)
3 Global Nanopharmaceuticals Competition Landscape by Players
3.1 Global Top Nanopharmaceuticals Players by Sales (2016-2021)
3.2 Global Top Nanopharmaceuticals Players by Revenue (2016-2021)
3.3 Global Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanopharmaceuticals as of 2020)
3.4 Global Nanopharmaceuticals Average Price by Company (2016-2021)
3.5 Manufacturers Nanopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Nanopharmaceuticals Market Size by Type
4.1 Global Nanopharmaceuticals Historic Market Review by Type (2016-2021)
4.1.1 Global Nanopharmaceuticals Sales Market Share by Type (2016-2021)
4.1.2 Global Nanopharmaceuticals Revenue Market Share by Type (2016-2021)
4.1.3 Global Nanopharmaceuticals Price by Type (2016-2021)
4.2 Global Nanopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Nanopharmaceuticals Sales Forecast by Type (2022-2027)
4.2.2 Global Nanopharmaceuticals Revenue Forecast by Type (2022-2027)
4.2.3 Global Nanopharmaceuticals Price Forecast by Type (2022-2027)
5 Global Nanopharmaceuticals Market Size by Application
5.1 Global Nanopharmaceuticals Historic Market Review by Application (2016-2021)
5.1.1 Global Nanopharmaceuticals Sales Market Share by Application (2016-2021)
5.1.2 Global Nanopharmaceuticals Revenue Market Share by Application (2016-2021)
5.1.3 Global Nanopharmaceuticals Price by Application (2016-2021)
5.2 Global Nanopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Nanopharmaceuticals Sales Forecast by Application (2022-2027)
5.2.2 Global Nanopharmaceuticals Revenue Forecast by Application (2022-2027)
5.2.3 Global Nanopharmaceuticals Price Forecast by Application (2022-2027)
6 North America Nanopharmaceuticals Market Facts & Figures
6.1 North America Nanopharmaceuticals Sales by Company
6.1.1 North America Nanopharmaceuticals Sales by Company (2016-2021)
6.1.2 North America Nanopharmaceuticals Revenue by Company (2016-2021)
6.2 North America Nanopharmaceuticals Sales Breakdown by Type
6.2.1 North America Nanopharmaceuticals Sales Breakdown by Type (2016-2021)
6.2.2 North America Nanopharmaceuticals Sales Breakdown by Type (2022-2027)
6.3 North America Nanopharmaceuticals Sales Breakdown by Application
6.3.1 North America Nanopharmaceuticals Sales Breakdown by Application (2016-2021)
6.3.2 North America Nanopharmaceuticals Sales Breakdown by Application (2022-2027)
7 Europe Nanopharmaceuticals Market Facts & Figures
7.1 Europe Nanopharmaceuticals Sales by Company
7.1.1 Europe Nanopharmaceuticals Sales by Company (2016-2021)
7.1.2 Europe Nanopharmaceuticals Revenue by Company (2016-2021)
7.2 Europe Nanopharmaceuticals Sales Breakdown by Type
7.2.1 Europe Nanopharmaceuticals Sales Breakdown by Type (2016-2021)
7.2.2 Europe Nanopharmaceuticals Sales Breakdown by Type (2022-2027)
7.3 Europe Nanopharmaceuticals Sales Breakdown by Application
7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)
8 China Nanopharmaceuticals Market Facts & Figures
8.1 China Nanopharmaceuticals Sales by Company
8.1.1 China Nanopharmaceuticals Sales by Company (2016-2021)
8.1.2 China Nanopharmaceuticals Revenue by Company (2016-2021)
8.2 China Nanopharmaceuticals Sales Breakdown by Type
8.2.1 China Nanopharmaceuticals Sales Breakdown by Type (2016-2021)
8.2.2 China Nanopharmaceuticals Sales Breakdown by Type (2022-2027)
8.3 China Nanopharmaceuticals Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Nanopharmaceuticals Market Facts & Figures
9.1 Japan Nanopharmaceuticals Sales by Company
9.1.1 Japan Nanopharmaceuticals Sales by Company (2016-2021)
9.1.2 Japan Nanopharmaceuticals Revenue by Company (2016-2021)
9.2 Japan Nanopharmaceuticals Sales Breakdown by Type
9.2.1 Japan Nanopharmaceuticals Sales Breakdown by Type (2016-2021)
9.2.2 Japan Nanopharmaceuticals Sales Breakdown by Type (2022-2027)
9.3 Japan Nanopharmaceuticals Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Nanopharmaceuticals Market Facts & Figures
10.1 Southeast Asia Nanopharmaceuticals Sales by Company
10.1.1 Southeast Asia Nanopharmaceuticals Sales by Company (2016-2021)
10.1.2 Southeast Asia Nanopharmaceuticals Revenue by Company (2016-2021)
10.2 Southeast Asia Nanopharmaceuticals Sales Breakdown by Type
10.2.1 Southeast Asia Nanopharmaceuticals Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Nanopharmaceuticals Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Nanopharmaceuticals Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Nanopharmaceuticals Market Facts & Figures
11.1 India Nanopharmaceuticals Sales by Company
11.1.1 India Nanopharmaceuticals Sales by Company (2016-2021)
11.1.2 India Nanopharmaceuticals Revenue by Company (2016-2021)
11.2 India Nanopharmaceuticals Sales Breakdown by Type
11.2.1 India Nanopharmaceuticals Sales Breakdown by Type (2016-2021)
11.2.2 India Nanopharmaceuticals Sales Breakdown by Type (2022-2027)
11.3 India Nanopharmaceuticals Sales Breakdown by Application
11.3.1 India Nanopharmaceuticals Sales Breakdown by Application (2016-2021)
11.3.2 India Nanopharmaceuticals Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Nanopharmaceuticals Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Nanopharmaceuticals Products Offered
12.1.5 Merck Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Nanopharmaceuticals Products Offered
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Nanopharmaceuticals Products Offered
12.3.5 Novartis Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Business Overview
12.4.3 Abbott Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Nanopharmaceuticals Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Business Overview
12.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline Nanopharmaceuticals Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Business Overview
12.6.3 Roche Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Roche Nanopharmaceuticals Products Offered
12.6.5 Roche Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Business Overview
12.7.3 Sanofi Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sanofi Nanopharmaceuticals Products Offered
12.7.5 Sanofi Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Business Overview
12.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Eli Lilly Nanopharmaceuticals Products Offered
12.8.5 Eli Lilly Recent Development
12.9 Astrazeneca
12.9.1 Astrazeneca Corporation Information
12.9.2 Astrazeneca Business Overview
12.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Astrazeneca Nanopharmaceuticals Products Offered
12.9.5 Astrazeneca Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Corporation Information
12.10.2 Johnson & Johnson Business Overview
12.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Johnson & Johnson Nanopharmaceuticals Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 Celgene
12.11.1 Celgene Corporation Information
12.11.2 Celgene Business Overview
12.11.3 Celgene Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Celgene Nanopharmaceuticals Products Offered
12.11.5 Celgene Recent Development
12.12 Novavax
12.12.1 Novavax Corporation Information
12.12.2 Novavax Business Overview
12.12.3 Novavax Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Novavax Nanopharmaceuticals Products Offered
12.12.5 Novavax Recent Development
12.13 Stryker
12.13.1 Stryker Corporation Information
12.13.2 Stryker Business Overview
12.13.3 Stryker Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Stryker Nanopharmaceuticals Products Offered
12.13.5 Stryker Recent Development
12.14 Gilead Sciences
12.14.1 Gilead Sciences Corporation Information
12.14.2 Gilead Sciences Business Overview
12.14.3 Gilead Sciences Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Gilead Sciences Nanopharmaceuticals Products Offered
12.14.5 Gilead Sciences Recent Development
12.15 OSI Pharmaceuticals
12.15.1 OSI Pharmaceuticals Corporation Information
12.15.2 OSI Pharmaceuticals Business Overview
12.15.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.15.4 OSI Pharmaceuticals Nanopharmaceuticals Products Offered
12.15.5 OSI Pharmaceuticals Recent Development
12.16 Kadmon Pharmaceuticals
12.16.1 Kadmon Pharmaceuticals Corporation Information
12.16.2 Kadmon Pharmaceuticals Business Overview
12.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Products Offered
12.16.5 Kadmon Pharmaceuticals Recent Development
12.17 Samyang Biopharm
12.17.1 Samyang Biopharm Corporation Information
12.17.2 Samyang Biopharm Business Overview
12.17.3 Samyang Biopharm Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Samyang Biopharm Nanopharmaceuticals Products Offered
12.17.5 Samyang Biopharm Recent Development
12.18 Mitsubishi Pharma
12.18.1 Mitsubishi Pharma Corporation Information
12.18.2 Mitsubishi Pharma Business Overview
12.18.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Mitsubishi Pharma Nanopharmaceuticals Products Offered
12.18.5 Mitsubishi Pharma Recent Development
12.19 Kaken Pharmaceutical
12.19.1 Kaken Pharmaceutical Corporation Information
12.19.2 Kaken Pharmaceutical Business Overview
12.19.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Kaken Pharmaceutical Nanopharmaceuticals Products Offered
12.19.5 Kaken Pharmaceutical Recent Development
12.20 Selecta Biosciences
12.20.1 Selecta Biosciences Corporation Information
12.20.2 Selecta Biosciences Business Overview
12.20.3 Selecta Biosciences Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Selecta Biosciences Nanopharmaceuticals Products Offered
12.20.5 Selecta Biosciences Recent Development
12.21 Par Pharmaceutical
12.21.1 Par Pharmaceutical Corporation Information
12.21.2 Par Pharmaceutical Business Overview
12.21.3 Par Pharmaceutical Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Par Pharmaceutical Nanopharmaceuticals Products Offered
12.21.5 Par Pharmaceutical Recent Development
12.22 Cerulean Pharma
12.22.1 Cerulean Pharma Corporation Information
12.22.2 Cerulean Pharma Business Overview
12.22.3 Cerulean Pharma Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Cerulean Pharma Nanopharmaceuticals Products Offered
12.22.5 Cerulean Pharma Recent Development
12.23 Navidea Biopharmaceuticals
12.23.1 Navidea Biopharmaceuticals Corporation Information
12.23.2 Navidea Biopharmaceuticals Business Overview
12.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Products Offered
12.23.5 Navidea Biopharmaceuticals Recent Development
12.24 Lummy
12.24.1 Lummy Corporation Information
12.24.2 Lummy Business Overview
12.24.3 Lummy Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Lummy Nanopharmaceuticals Products Offered
12.24.5 Lummy Recent Development
13 Nanopharmaceuticals Manufacturing Cost Analysis
13.1 Nanopharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nanopharmaceuticals
13.4 Nanopharmaceuticals Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nanopharmaceuticals Distributors List
14.3 Nanopharmaceuticals Customers
15 Market Dynamics
15.1 Nanopharmaceuticals Market Trends
15.2 Nanopharmaceuticals Drivers
15.3 Nanopharmaceuticals Market Challenges
15.4 Nanopharmaceuticals Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Nanopharmaceuticals Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Nanopharmaceuticals Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Nanopharmaceuticals Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Nanopharmaceuticals Sales (K MT) by Region (2016-2021)
Table 5. Global Nanopharmaceuticals Sales Market Share by Region (2016-2021)
Table 6. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Nanopharmaceuticals Revenue Share by Region (2016-2021)
Table 8. Global Nanopharmaceuticals Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Nanopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Nanopharmaceuticals Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Nanopharmaceuticals Revenue Share Forecast by Region (2022-2027)
Table 12. Global Nanopharmaceuticals Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Nanopharmaceuticals Sales Share by Company (2016-2021)
Table 14. Global Nanopharmaceuticals Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Nanopharmaceuticals Revenue Share by Company (2016-2021)
Table 16. Global Nanopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanopharmaceuticals as of 2020)
Table 17. Global Nanopharmaceuticals Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Nanopharmaceuticals Manufacturing Sites and Area Served
Table 19. Manufacturers Nanopharmaceuticals Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Nanopharmaceuticals Sales (K MT) by Type (2016-2021)
Table 22. Global Nanopharmaceuticals Sales Share by Type (2016-2021)
Table 23. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Nanopharmaceuticals Price (USD/MT) by Type (2016-2021)
Table 25. Global Nanopharmaceuticals Sales Share by Type (2022-2027)
Table 26. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Nanopharmaceuticals Revenue Share by Type (2022-2027)
Table 28. Global Nanopharmaceuticals Price (USD/MT) by Type (2022-2027)
Table 29. Global Nanopharmaceuticals Sales (K MT) by Application (2016-2021)
Table 30. Global Nanopharmaceuticals Sales Share by Application (2016-2021)
Table 31. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Nanopharmaceuticals Price (USD/MT) by Application (2016-2021)
Table 33. Global Nanopharmaceuticals Sales (K MT) by Application (2022-2027)
Table 34. Global Nanopharmaceuticals Sales Share by Application (2022-2027)
Table 35. Global Nanopharmaceuticals Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Nanopharmaceuticals Revenue Share by Application (2022-2027)
Table 37. Global Nanopharmaceuticals Price (USD/MT) by Application (2022-2027)
Table 38. North America Nanopharmaceuticals Sales (K MT) by Company (2016-2021)
Table 39. North America Nanopharmaceuticals Sales Market Share by Company (2016-2021)
Table 40. North America Nanopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Nanopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 42. North America Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)
Table 43. North America Nanopharmaceuticals Sales Market Share by Type (2016-2021)
Table 44. North America Nanopharmaceuticals Sales by Type (2022-2027) & (K MT)
Table 45. North America Nanopharmaceuticals Sales Market Share by Type (2022-2027)
Table 46. North America Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)
Table 47. North America Nanopharmaceuticals Sales Market Share by Application (2016-2021)
Table 48. North America Nanopharmaceuticals Sales by Application (2022-2027) & (K MT)
Table 49. North America Nanopharmaceuticals Sales Market Share by Application (2022-2027)
Table 50. Europe Nanopharmaceuticals Sales (K MT) by Company (2016-2021)
Table 51. Europe Nanopharmaceuticals Sales Market Share by Company (2016-2021)
Table 52. Europe Nanopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Nanopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 54. Europe Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)
Table 55. Europe Nanopharmaceuticals Sales Market Share by Type (2016-2021)
Table 56. Europe Nanopharmaceuticals Sales by Type (2022-2027) & (K MT)
Table 57. Europe Nanopharmaceuticals Sales Market Share by Type (2022-2027)
Table 58. Europe Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)
Table 59. Europe Nanopharmaceuticals Sales Market Share by Application (2016-2021)
Table 60. Europe Nanopharmaceuticals Sales by Application (2022-2027) & (K MT)
Table 61. Europe Nanopharmaceuticals Sales Market Share by Application (2022-2027)
Table 62. China Nanopharmaceuticals Sales (K MT) by Company (2016-2021)
Table 63. China Nanopharmaceuticals Sales Market Share by Company (2016-2021)
Table 64. China Nanopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Nanopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 66. China Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)
Table 67. China Nanopharmaceuticals Sales Market Share by Type (2016-2021)
Table 68. China Nanopharmaceuticals Sales by Type (2022-2027) & (K MT)
Table 69. China Nanopharmaceuticals Sales Market Share by Type (2022-2027)
Table 70. China Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)
Table 71. China Nanopharmaceuticals Sales Market Share by Application (2016-2021)
Table 72. China Nanopharmaceuticals Sales by Application (2022-2027) & (K MT)
Table 73. China Nanopharmaceuticals Sales Market Share by Application (2022-2027)
Table 74. Japan Nanopharmaceuticals Sales (K MT) by Company (2016-2021)
Table 75. Japan Nanopharmaceuticals Sales Market Share by Company (2016-2021)
Table 76. Japan Nanopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Nanopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 78. Japan Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)
Table 79. Japan Nanopharmaceuticals Sales Market Share by Type (2016-2021)
Table 80. Japan Nanopharmaceuticals Sales by Type (2022-2027) & (K MT)
Table 81. Japan Nanopharmaceuticals Sales Market Share by Type (2022-2027)
Table 82. Japan Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)
Table 83. Japan Nanopharmaceuticals Sales Market Share by Application (2016-2021)
Table 84. Japan Nanopharmaceuticals Sales by Application (2022-2027) & (K MT)
Table 85. Japan Nanopharmaceuticals Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Nanopharmaceuticals Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Nanopharmaceuticals Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Nanopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Nanopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Nanopharmaceuticals Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Nanopharmaceuticals Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Nanopharmaceuticals Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Nanopharmaceuticals Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Nanopharmaceuticals Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Nanopharmaceuticals Sales Market Share by Application (2022-2027)
Table 98. India Nanopharmaceuticals Sales (K MT) by Company (2016-2021)
Table 99. India Nanopharmaceuticals Sales Market Share by Company (2016-2021)
Table 100. India Nanopharmaceuticals Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Nanopharmaceuticals Revenue Market Share by Company (2016-2021)
Table 102. India Nanopharmaceuticals Sales by Type (2016-2021) & (K MT)
Table 103. India Nanopharmaceuticals Sales Market Share by Type (2016-2021)
Table 104. India Nanopharmaceuticals Sales by Type (2022-2027) & (K MT)
Table 105. India Nanopharmaceuticals Sales Market Share by Type (2022-2027)
Table 106. India Nanopharmaceuticals Sales by Application (2016-2021) & (K MT)
Table 107. India Nanopharmaceuticals Sales Market Share by Application (2016-2021)
Table 108. India Nanopharmaceuticals Sales by Application (2022-2027) & (K MT)
Table 109. India Nanopharmaceuticals Sales Market Share by Application (2022-2027)
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Merck Nanopharmaceuticals Product
Table 114. Merck Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Pfizer Nanopharmaceuticals Product
Table 119. Pfizer Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Novartis Nanopharmaceuticals Product
Table 124. Novartis Recent Development
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Abbott Nanopharmaceuticals Product
Table 129. Abbott Recent Development
Table 130. GlaxoSmithKline Corporation Information
Table 131. GlaxoSmithKline Description and Business Overview
Table 132. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. GlaxoSmithKline Nanopharmaceuticals Product
Table 134. GlaxoSmithKline Recent Development
Table 135. Roche Corporation Information
Table 136. Roche Description and Business Overview
Table 137. Roche Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Roche Nanopharmaceuticals Product
Table 139. Roche Recent Development
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Business Overview
Table 142. Sanofi Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Sanofi Nanopharmaceuticals Product
Table 144. Sanofi Recent Development
Table 145. Eli Lilly Corporation Information
Table 146. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Eli Lilly Description and Business Overview
Table 148. Eli Lilly Nanopharmaceuticals Product
Table 149. Eli Lilly Recent Development
Table 150. Astrazeneca Corporation Information
Table 151. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Astrazeneca Description and Business Overview
Table 153. Astrazeneca Nanopharmaceuticals Product
Table 154. Astrazeneca Recent Development
Table 155. Johnson & Johnson Corporation Information
Table 156. Johnson & Johnson Description and Business Overview
Table 157. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Johnson & Johnson Nanopharmaceuticals Product
Table 159. Johnson & Johnson Recent Development
Table 160. Celgene Corporation Information
Table 161. Celgene Description and Business Overview
Table 162. Celgene Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Celgene Nanopharmaceuticals Product
Table 164. Celgene Recent Development
Table 165. Novavax Corporation Information
Table 166. Novavax Description and Business Overview
Table 167. Novavax Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Novavax Nanopharmaceuticals Product
Table 169. Novavax Recent Development
Table 170. Stryker Corporation Information
Table 171. Stryker Description and Business Overview
Table 172. Stryker Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Stryker Nanopharmaceuticals Product
Table 174. Stryker Recent Development
Table 175. Gilead Sciences Corporation Information
Table 176. Gilead Sciences Description and Business Overview
Table 177. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Gilead Sciences Nanopharmaceuticals Product
Table 179. Gilead Sciences Recent Development
Table 180. OSI Pharmaceuticals Corporation Information
Table 181. OSI Pharmaceuticals Description and Business Overview
Table 182. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. OSI Pharmaceuticals Nanopharmaceuticals Product
Table 184. OSI Pharmaceuticals Recent Development
Table 185. Kadmon Pharmaceuticals Corporation Information
Table 186. Kadmon Pharmaceuticals Description and Business Overview
Table 187. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Kadmon Pharmaceuticals Nanopharmaceuticals Product
Table 189. Kadmon Pharmaceuticals Recent Development
Table 190. Samyang Biopharm Corporation Information
Table 191. Samyang Biopharm Description and Business Overview
Table 192. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. Samyang Biopharm Nanopharmaceuticals Product
Table 194. Samyang Biopharm Recent Development
Table 195. Mitsubishi Pharma Corporation Information
Table 196. Mitsubishi Pharma Description and Business Overview
Table 197. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 198. Mitsubishi Pharma Nanopharmaceuticals Product
Table 199. Mitsubishi Pharma Recent Development
Table 200. Kaken Pharmaceutical Corporation Information
Table 201. Kaken Pharmaceutical Description and Business Overview
Table 202. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 203. Kaken Pharmaceutical Nanopharmaceuticals Product
Table 204. Kaken Pharmaceutical Recent Development
Table 205. Selecta Biosciences Corporation Information
Table 206. Selecta Biosciences Description and Business Overview
Table 207. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 208. Selecta Biosciences Nanopharmaceuticals Product
Table 209. Selecta Biosciences Recent Development
Table 210. Par Pharmaceutical Corporation Information
Table 211. Par Pharmaceutical Description and Business Overview
Table 212. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 213. Par Pharmaceutical Nanopharmaceuticals Product
Table 214. Par Pharmaceutical Recent Development
Table 215. Cerulean Pharma Corporation Information
Table 216. Cerulean Pharma Description and Business Overview
Table 217. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 218. Cerulean Pharma Nanopharmaceuticals Product
Table 219. Cerulean Pharma Recent Development
Table 220. Navidea Biopharmaceuticals Corporation Information
Table 221. Navidea Biopharmaceuticals Description and Business Overview
Table 222. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 223. Navidea Biopharmaceuticals Nanopharmaceuticals Product
Table 224. Navidea Biopharmaceuticals Recent Development
Table 225. Lummy Corporation Information
Table 226. Lummy Description and Business Overview
Table 227. Lummy Nanopharmaceuticals Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 228. Lummy Nanopharmaceuticals Product
Table 229. Lummy Recent Development
Table 230. Production Base and Market Concentration Rate of Raw Material
Table 231. Key Suppliers of Raw Materials
Table 232. Nanopharmaceuticals Distributors List
Table 233. Nanopharmaceuticals Customers List
Table 234. Nanopharmaceuticals Market Trends
Table 235. Nanopharmaceuticals Market Drivers
Table 236. Nanopharmaceuticals Market Challenges
Table 237. Nanopharmaceuticals Market Restraints
Table 238. Research Programs/Design for This Report
Table 239. Key Data Information from Secondary Sources
Table 240. Key Data Information from Primary Sources
List of Figures
Figure 1. Nanopharmaceuticals Product Picture
Figure 2. Global Nanopharmaceuticals Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Nanopharmaceuticals Sales Market Share by Application in 2021 & 2027
Figure 6. Cancer and Tumor Examples
Figure 7. Autoimmune Disorders Examples
Figure 8. Inflammation Examples
Figure 9. Others Examples
Figure 10. Global Nanopharmaceuticals Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Nanopharmaceuticals Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Nanopharmaceuticals Sales (K MT) Growth Rate (2016-2027)
Figure 13. Global Nanopharmaceuticals Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 14. Global Nanopharmaceuticals Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Nanopharmaceuticals Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Nanopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Nanopharmaceuticals Sales (K MT) Growth Rate (2016-2027)
Figure 18. Europe Nanopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Nanopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Nanopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Nanopharmaceuticals Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Nanopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Nanopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Nanopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Nanopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Nanopharmaceuticals Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Nanopharmaceuticals Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Nanopharmaceuticals Players Market Share by Revenue in Nanopharmaceuticals: 2016 & 2020
Figure 29. Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Nanopharmaceuticals Revenue Share by Type (2016-2021)
Figure 31. Global Nanopharmaceuticals Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Nanopharmaceuticals Revenue Share by Application (2016-2021)
Figure 33. Global Nanopharmaceuticals Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Nanopharmaceuticals Sales Market Share by Type in 2020
Figure 35. North America Nanopharmaceuticals Sales Market Share by Application in 2020
Figure 36. Europe Nanopharmaceuticals Sales Market Share by Type in 2020
Figure 37. Europe Nanopharmaceuticals Sales Market Share by Application in 2020
Figure 38. China Nanopharmaceuticals Sales Market Share by Type in 2020
Figure 39. China Nanopharmaceuticals Sales Market Share by Application in 2020
Figure 40. Japan Nanopharmaceuticals Sales Market Share by Type in 2020
Figure 41. Japan Nanopharmaceuticals Sales Market Share by Application in 2020
Figure 42. Southeast Asia Nanopharmaceuticals Sales Market Share by Type in 2020
Figure 43. Southeast Asia Nanopharmaceuticals Sales Market Share by Application in 2020
Figure 44. India Nanopharmaceuticals Sales Market Share by Type in 2020
Figure 45. India Nanopharmaceuticals Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Nanopharmaceuticals
Figure 48. Manufacturing Process Analysis of Nanopharmaceuticals
Figure 49. Nanopharmaceuticals Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界の固形腫瘍がん治療市場規模・現状・予測（2021年-2027年） An abnormal mass of tissue that usually does not contain cysts or liquid areas. Market Analysis and Insights: Global Solid Tumor Cancer Treatment Market The global Solid Tumor Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% dur…- 世界のがん腫瘍プロファイリング市場規模・現状・予測（2021年-2027年） Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of …
- 腫瘍アブレーションのグローバル市場2021 This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requ…
- 金ナノ粒子のグローバル市場2021 Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug …
- 世界の腫瘍ラジオ波焼灼療法市場規模・現状・予測（2021年-2027年） Radiofrequency ablation (or RFA) is a procedure used to reduce pain. An electrical current produced by a radio wave is used to heat up a small area of nerve tissue, thereby decreasing pain signals from that specific area. Market Analysis and Insights: Global Tumor Radiofrequency Ablation Market The …